Drugs News and Research

RSS

Scientists identify gene variant that predisposes people to special type of heart attack

Scientists at The University of Manchester and medical institutes in Italy have identified a gene variant that predisposes people to a special type of heart attack.

From The University of Manchester 10 Sep 2013

Researchers discover why multiple myeloma persistently escapes cure

Clinical researchers at Princess Margaret Cancer Centre have discovered why multiple myeloma, an incurable cancer of the bone marrow, persistently escapes cure by an initially effective treatment that can keep the disease at bay for up to several years.

10 Sep 2013

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

10 Sep 2013

Combined transplantation provides potential new therapy for repair of spinal cord injury

Following spinal cord injury, astrocyte proliferation and scar formation are the main factors inhibiting the regeneration and growth of spinal cord axons, leading to motor and sensory function loss below the level of spinal cord injury.

10 Sep 2013

New technology to diagnose influenza quickly

A new technology is showing promise as the basis for a much-needed home test to diagnose influenza quickly, before the window for taking antiviral drugs slams shut and sick people spread the virus to others, scientists reported here today. In a presentation at the 246th National Meeting & Exposition of the American Chemical Society (ACS), they described how it also could determine the specific strain of flu virus and help select the most effective drug for treatment.

10 Sep 2013

Biogen Idec And Isis Ink Fourth Deal In Two Years

...

9 Sep 2013

Pemetrexed-erlotinib shows second-line efficacy in advanced NSCLC

Combination therapy with pemetrexed and erlotinib significantly improves progression-free survival as compared with either drug alone in patients with advanced non-squamous non-small-cell lung cancer, a phase II study has found.

9 Sep 2013

Hepatitis C services in the UK: an interview with Louise Campbell, senior liver nurse at Imperial College Healthcare NHS Trust

Within the UK there are several centres whose nurse specialists work to a best practice model, delivering care and achieving outcomes which are extremely high in areas of patient retention, adherence to medication and completion of the treatment regimen. With this they achieve cure rates which are some of the highest in the World.

9 Sep 2013

New pilot program for parents whose children are struggling with drug and alcohol problems

The Partnership at Drugfree.org, the nation's largest nonprofit organization dedicated to finding evidence-based solutions to adolescent substance use disorders, has announced a new, pioneering pilot program specifically for parents whose children are struggling with drug and alcohol problems.

7 Sep 2013

Amendments to oral cancer bill would increase co-pay for oral cancer treatment, says NPAF

Citing the hardships certain to be faced by a population of California cancer patients on strained incomes, the National Patient Advocate Foundation (NPAF), a national non-profit organization providing the patient voice for legislative reform at the state and federal levels, pulled its support for AB 219 following amendments passed in the California state senate yesterday that would prohibitively increase the co-pay for oral cancer treatment.

7 Sep 2013

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

7 Sep 2013

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

D&A PHARMA, a leading company in the Addiction therapeutic area, announces today its strong participation in the 14th Congress of European Company of Biomedical Search on the Alcoholism (ESBRA), which will be held in Warsaw from September 8th to 11th.

7 Sep 2013

Medivir discontinues development of hepatitis B compound MIV-210 on collaboration with Daewoong

Medivir AB today announced that it has discontinued the development of its hepatitis B compound MIV-210 based on a joint decision with Daewoong Pharmaceutical Co. Ltd.,.

7 Sep 2013

'Flurry' of new reports show wide variations on insurance rate costs

News outlets continue to follow recent studies released by several health policy groups about the expected premiums for plans offered on the new online insurance marketplaces.

7 Sep 2013

New flexible microneedle patch allows drugs to deliver directly through skin

An assistant professor with the Virginia Tech - Wake Forest School of Biomedical Engineering has developed a flexible microneedle patch that allows drugs to be delivered directly and fully through the skin. The new patch can quicken drug delivery time while cutting waste, and can likely minimize side-effects in some cases, notable in vaccinations and cancer therapy.

7 Sep 2013

Human Urine Metabolome Study Envisions New Diagnostic Era

...

6 Sep 2013

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

TechAtlas Group has announced the release of the latest Type 1 Diabetes competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development.

6 Sep 2013

Medivir, Daewoong Discontinue HBV Drug Development

...

6 Sep 2013

More than 3,000 chemicals or "metabolites" can be detected in urine, say researchers

Researchers at the University of Alberta announced today that they have determined the chemical composition of human urine. The study, which took more than seven years and involved a team of nearly 20 researchers, has revealed that more than 3,000 chemicals or "metabolites" can be detected in urine.

6 Sep 2013

Researchers explore distinctions between natural sleep and anesthetic unconsciousness

Falling asleep in your bed at night and being "put to sleep" under general anesthesia - as well as waking up in the morning or coming out of anesthesia - aren't quite the same thing, yet they share some important similarities. Max Kelz, MD, PhD, assistant professor of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania, along with colleagues from Penn, UCSD, Howard Hughes Medical Institute, and Thomas Jefferson University, explored the distinctions between anesthetic unconsciousness and sleep by manipulating the genetic pathways known to be involved in natural sleep and studying the resulting effects on anesthetic states.

6 Sep 2013

Drugs News and Research

Scientists identify gene variant that predisposes people to special type of heart attack

Researchers discover why multiple myeloma persistently escapes cure

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Combined transplantation provides potential new therapy for repair of spinal cord injury

New technology to diagnose influenza quickly

Biogen Idec And Isis Ink Fourth Deal In Two Years

Pemetrexed-erlotinib shows second-line efficacy in advanced NSCLC

Hepatitis C services in the UK: an interview with Louise Campbell, senior liver nurse at Imperial College Healthcare NHS Trust

New pilot program for parents whose children are struggling with drug and alcohol problems

Amendments to oral cancer bill would increase co-pay for oral cancer treatment, says NPAF

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

D&A PHARMA to present 3 clinical studies for ALCOVER in 14th Congress of ESBRA at Warsaw

Medivir discontinues development of hepatitis B compound MIV-210 on collaboration with Daewoong

'Flurry' of new reports show wide variations on insurance rate costs

New flexible microneedle patch allows drugs to deliver directly through skin

Human Urine Metabolome Study Envisions New Diagnostic Era

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

Medivir, Daewoong Discontinue HBV Drug Development

More than 3,000 chemicals or "metabolites" can be detected in urine, say researchers

Researchers explore distinctions between natural sleep and anesthetic unconsciousness

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News